BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34731120)

  • 1. Cervical cancer screening varies by HPV vaccination status among a National Cohort of privately insured young women in the United States 2006-2016.
    Ba DM; McCall-Hosenfeld JS; Ssentongo P; Chinchilli VM; Agbese E; Liu G; Leslie DL; Du P
    Medicine (Baltimore); 2021 Oct; 100(41):e27457. PubMed ID: 34731120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study.
    Castanon A; Landy R; Pesola F; Windridge P; Sasieni P
    Lancet Public Health; 2018 Jan; 3(1):e34-e43. PubMed ID: 29307386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.
    Gertig DM; Brotherton JM; Budd AC; Drennan K; Chappell G; Saville AM
    BMC Med; 2013 Oct; 11():227. PubMed ID: 24148310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Retrospective Cohort Study of Young Women Spontaneously Choosing to Be Vaccinated against HPV: Outcomes from Their First Cervical Cancer Screening Test.
    Del Mistro A; Battagello J; Weis L; Bressan V; Selle V; Ramigni M; Dal Zotto A; Maggiolo A; Gori S; Frayle H; Zappa M; Zorzi M; The Consensus Study Veneto Working Group
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33809436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Differential Risk of Cervical Cancer in HPV-Vaccinated and -Unvaccinated Women: A Mathematical Modeling Study.
    Naslazi E; Hontelez JAC; Naber SK; van Ballegooijen M; de Kok IMCM
    Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):912-919. PubMed ID: 33837119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does HPV vaccination status relate to risk perceptions and intention to participate in cervical screening? a survey study.
    Hestbech MS; Gyrd-Hansen D; Kragstrup J; Siersma V; Brodersen J
    BMC Public Health; 2016 Aug; 15():708. PubMed ID: 27488178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Papillomavirus Vaccination and Cervical Cytology Outcomes Among Urban Low-Income Minority Females.
    Hofstetter AM; Ompad DC; Stockwell MS; Rosenthal SL; Soren K
    JAMA Pediatr; 2016 May; 170(5):445-52. PubMed ID: 26974250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between prior HPV4 vaccine doses and cervical cancer screening participation.
    Boone SD; Pinkston CM; Baumgartner KB; Baumgartner RN; Harper SM; Bonham AJ; Paynter CA; Harper DM
    Cancer Epidemiol; 2016 Jun; 42():108-14. PubMed ID: 27100836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study.
    Rodriguez AM; Zeybek B; Vaughn M; Westra J; Kaul S; Montealegre JR; Lin YL; Kuo YF
    Cancer; 2020 Apr; 126(8):1656-1667. PubMed ID: 32037524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missed Opportunities for HPV Vaccination Among Vaccine-Eligible Women with High Grade Cervical Lesions.
    Russ SM; Brackney M; Meek J; Niccolai LM
    Vaccine; 2019 Jul; 37(31):4262-4267. PubMed ID: 31248688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic HPV vaccination at age 16-23 and cervical screening attendance in Sweden: a national register-based cohort study.
    Kreusch T; Wang J; Sparén P; Sundström K
    BMJ Open; 2018 Oct; 8(10):e024477. PubMed ID: 30282687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country.
    Velentzis LS; Caruana M; Simms KT; Lew JB; Shi JF; Saville M; Smith MA; Lord SJ; Tan J; Bateson D; Quinn M; Canfell K
    Int J Cancer; 2017 Dec; 141(12):2410-2422. PubMed ID: 28801947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of human papillomavirus vaccination on rates of abnormal cervical cytology and histology in young New Zealand women.
    Innes CR; Williman JA; Simcock BJ; Hider P; Sage M; Dempster-Rivett K; Lawton BA; Sykes PH
    N Z Med J; 2020 Jan; 133(1508):72-84. PubMed ID: 31945044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status of HPV vaccination among HPV-infected women aged 20-60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study.
    Seong J; Ryou S; Yoo M; Lee J; Kim K; Jee Y; Cho CH; Kim SM; Hong SR; Jeong DH; Lee WC; Park JS; Kim TJ; Kee MK
    J Gynecol Oncol; 2020 Jan; 31(1):e4. PubMed ID: 31788994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between HPV vaccination among women and their 11-14-year-old children.
    Kornides M; Head KJ; Feemster K; Zimet GD; Panozzo CA
    Hum Vaccin Immunother; 2019; 15(7-8):1824-1830. PubMed ID: 31295048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening rate differs by HPV vaccination status: An interim analysis.
    Taniguchi M; Ueda Y; Yagi A; Ikeda S; Endo M; Tomimatsu T; Nakayama T; Sekine M; Enomoto T; Kimura T
    Vaccine; 2019 Jul; 37(32):4424-4426. PubMed ID: 31272873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
    Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
    Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
    Guo F; Hirth JM; Berenson AB
    J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.